Signet-ring cell carcinoma is classified in poorly differentiated adenocarcinoma with an aggressive nature and a poor prognosis. We have shown that the activation of PI 3-kinase in highly differentiated adenocarcinomas induces loss of cell-cell contact and formation of vacuoles, giving phenotypes similar to those of signet-ring cell lines. SB203580, a potent p38 MAP kinase inhibitor, blocked this transition, and expression of an active form of MKK6 (MKK6DA), an activator of p38 MAP kinase, gave effects similar to those induced by expression of the active form of PI 3-kinase (BD110), although formation of large vacuoles was not induced. Activation of MKK3, another activator of p38 MAP kinase, was activated in native signet-ring carcinoma cell lines. Anchorage-independent growth of signet-ring cell lines was inhibited by LY294002 or SB203580. These results suggest that p38 MAP kinase is functioning downstream of PI 3-kinase in signaling of the malignant phenotype. Secretion of mucins was enhanced in BD110-expressing cells, but not in MKK6DA-expressing cells, suggesting that secretion of mucins is independent of the MKK6-p38 MAP kinase cascade. Thus, there may be at least two pathways, p38 MAP kinase-dependent and -independent, which are involved in regulation of cell-cell contact and the protein secretion system, respectively.
Introduction
Gastric carcinomas are classified into two groups, differentiated and undifferentiated (or poorly differentiated) adenocarcinomas, according to their histologic features. Differentiated adenocarcinomas usually form glandular tumors with aggregates or masses of cells, whereas undifferentiated adenocarcinomas form tumors composed of solitary cells or small clusters of cells without forming glands, which can be due to reduction or loss of cell-cell interaction (Tahara, 1989) .
Signet-ring cell carcinoma is one of the most malignant types of undifferentiated adenocarcinoma, which is characterized by a vacuolated cytoplasm and eccentrically placed, crescent-shaped nuclei (Duane and Kanter, 1985) . Mutation of the E-cadherin gene (Oda et al., 1994) and/or the a-catenin gene (Maeno et al., 1999) is often observed in this cancer. However, it is not clear whether these mutations are indispensable for the malignant phenotypes. The molecular mechanism for the formation of signet-ring cell carcinoma remains largely unknown. We have shown that welldifferentiated adenocarcinoma cells could be converted to signet-ring cell carcinoma-like cells by expression of constitutively active PI 3-kinase (BD110) (Kita et al., 1998; Kobayashi et al., 1999) . These cells show loss of cell-cell contact and the occasional appearance of large vacuoles containing mucus droplets in the cytoplasm. It is likely that stimulation of the secretion system in these cells results in enlargement of ER or the Golgi Complex to form large vacuoles (Kobayashi et al., 1999) . As a result, these cells gain malignant properties, promoting anchorage-independent growth in soft agar and forming poorly differentiated tumors in nude mice. Mice transplanted with these cells had a shorter lifespan than did mice transplanted with parental cells (Kobayashi et al., 1999) . These results suggested that PI 3-kinase indeed contributes to the malignant phenotype of signet-ring cell carcinomas.
Recently, we found that PI 3-kinase was often activated by binding to ErbB3 in signet-ring cell lines (Kobayashi et al., 2003) . In these cells, ErbB2 was activated as well, suggesting that the ErbB2/ErbB3 complex may play a role in the formation of signet-ring cell carcinomas. Introduction of constitutively active ErbB3 in a differentiated adenocarcinoma cell line, HCC2998, resulted in loss of cell-cell contact and high expression of mucin (MUC1), a marker of malignant tumors (Yonezawa and Sato, 1997; Kobayashi et al., 2003) . However, the function of the downstream molecules of PI 3-kinase in the formation of signet-ring cell carcinoma remains elusive.
Since phosphorylation of p38 MAP kinase was observed in cells exhibiting morphologic change induced by active PI 3-kinase expression and in native signet-ring cell carcinoma lines such as NUGC4 and KATOIII (Kobayashi et al., 1999) , we focused on p38 MAP kinase. Our results suggest that p38 MAP kinase contributes to the morphologic change and the malignant phenotype of signet-ring cell carcinomas.
Results

p38 MAP kinase is involved in morphologic change of differentiated adenocarcinoma cell lines
To investigate the role of p38 MAP kinase in the formation of signet-ring cell carcinoma, we first tested the effect of SB203580, a potent p38 MAP kinase inhibitor, on conversion of well-differentiated adenocarcinomas to poorly differentiated ones by expression of constitutively active PI 3-kinase (BD110). We have demonstrated that induction of BD110 in two well-differentiated gastric adenocarcinoma cell lines (HCC2998/BD110 and MKN45-1/BD110) by use of the Cre-LoxP system resulted in loss of cell-cell interaction and in rounding of the cells and formation of signet-ring-like cells containing huge vacuoles in the cytoplasm (Figure 1a ). These morphologic changes were inhibited by SB203580 in a dose-dependent manner, although the formation of large vacuoles was not inhibited by SB203580 (Figure 1a ). This suggests that p38 MAP kinase may be a major downstream factor of PI 3-kinase in the formation of signet-ring cell carcinomas. It has been shown that MKK3 or MKK6 activates p38 MAP kinase (Raingeaud et al., 1996) . For confirmation of this idea, constitutively active MKK6 (dominant-active MKK6, MKK6DA) (Raingeaud et al., 1995) , a direct activator of p38 MAP kinase, was expressed in HCC2998/BD110 cells together with GFP, and the morphology of the transfected cells was observed under a fluorescence microscope. Rounding Role of p38 MAP kinase in differentiation of carcinoma Q Xu et al of the cells, similar to that of BD110-expressing cells, was observed, which was also inhibited by SB203580, although formation of large vacuoles was not observed (Figure 1b, c) . These results suggest that the MKK3/6-p38 MAP kinase cascade is downstream of PI 3-kinase in regulating cell-cell contact.
MKK6DA induces rounding of HCC2998 cells
We established stable transformants of HCC2998 cells capable of expressing MKK6DA. HCC2998 cells were transfected with the vector carrying the MKK6DA gene, whose expression was controlled by the Cre-loxP system (Kanegae et al., 1995) . After neomycin selection, five cell lines containing the MKK6DA gene were established. Activation of the MKK6/p38 MAP kinase pathway after the gene expression in these cells was confirmed by examination of the phosphorylation of p38 by Western blotting after infection with AxCANCre coding for Cre recombinase ( Figure 2a ). Induction of the MKK6DA gene resulted in rounding of the cells, which was inhibited by SB203580 ( Figure 2b ). Similar results were observed in the other cell lines established at the same time (data not shown). It is important to note that much fewer vacuoles were formed in these cells compared with the cells expressing BD110.
Signaling from PI 3-kinase to MKK3/6 is mediated by Rac
To determine the signaling pathway from PI 3-kinase to MKK3/6, we tested the effect of Rac on the morphology of HCC2998/BD110 cells. It has been known that Rac can be activated downstream of PI 3-kinase, which, in turn, can activate the p38 MAP kinase pathway through p21-activated protein kinase 1 (PAK1) (Zhang et al., 1995) . First, phosphorylation of p38 MAP kinase by constitutively active Rac (dominant-active Rac, Rac-DA) in HCC2998 cells was tested.
Expression of RacDA resulted in rounding of the cells (Figure 3a, b) , although the percentage of cells with a round shape caused by RacDA (41.0%) was less than that caused by BD110 (68.2%) and MKK6DA (82.3%). This morphologic change was inhibited by SB203580 (Figure 3a) , suggesting that the Rac-MKK3/6-p38 MAP kinase pathway is involved in the morphologic change. In addition, dominant-negative Rac (RacDN) inhibited the morphologic change induced by BD110, but not that induced by MKK6DA (Figure 3a , b). Dominant-active Rho or Cdc42 showed little effect on the cell morphology (data not shown). These results suggest that Rac mediates signaling from PI 3-kinase to p38 MAP kinase in these cells. As shown in Figures 3c and d , phosphorylation of p38 MAP kinase was enhanced by RacDA, although more weakly than that caused by expression of BD110 or MKK6DA. This suggests that the PI 3-kinase-Rac-MKK3/6 pathway is present in these cells.
MKK3 is activated in NUGC4 and KATOIII cells
Attempt was done to see whether or not PI 3-kinaseRac-MKK3/6 was indeed activated in signet-ring cell carcinoma lines. Use of anti-phospho-MKK3/6 antibody revealed that MKK3 was activated in NUGC4 and KATOIII cells, which was not detected in HCC2998 cells ( Figure 3e ). Activation of MKK6 was undetectable. The active form of Rac was also detected; however, it was hard to compare the activation levels among the cell lines because any of the cells showed activation of Rac to some extent. These results suggest that PI 3-kinaseRac-MKK3-p38 MAP kinase pathway is activated in these cells.
MUC1 secretion is independent of the MKK3/6-p38 MAP kinase pathway
One of the typical phenotypes of signet-ring cell carcinomas is the formation of large vacuoles. We have shown that this is because of enhancement of the secretion system by activation of PI 3-kinase (Kobayashi et al., 1999) . Reflecting this fact, mucins are abundantly secreted in signet-ring cell carcinomas. We have suggested that activation of ErbB3 enhanced secretion of MUC1 through a PI 3-kinase-mediated signaling pathway (Kobayashi et al., 2003) . We tested whether the secretion system is activated by the MKK3/ 6-p38 MAP kinase pathway by immunostaining with anti-MUC1 antibody. In native signet-ring cell Role of p38 MAP kinase in differentiation of carcinoma Q Xu et al carcinoma lines whose ErbB3-PI 3-kinase pathway was activated, SB203580 did not affect the secretion of MUC1 in these cell lines (Figure 4a ), whereas LY294002 completely suppressed this secretion (Figure 4a ). In a similar way, enhancement of MUC1 secretion in HCC2998 cells expressing BD110 was inhibited by LY294002, but not by SB203580 (Figure 4b ). Expression of MKK6DA in HCC2998 cells did not enhance the secretion of MUC1, supporting the idea that secretion of MUC1 is independent of the MKK3/ 6-p38 MAP kinase pathway (Figure 4b ). Similar results were obtained by use of transient expression vectors of BD110 and MKK6DA (Figure 5a, b) .
Anchorage-independent growth of signet-ring cell carcinoma lines is inhibited by SB203580 or LY294002
To investigate the contribution of p38 MAP kinase to the malignancy of signet-ring cell carcinomas, we tested the effect of SB203580 on the anchorage-independent growth of two signet-ring cell lines, NUGC4 and KATOIII, in soft agar. As expected, these cells formed large colonies (Figure 6 ). In contrast, both cell lines failed to grow in soft agar in the presence of LY294002 ( Figure 6 ). Although less effective, SB203580 also inhibited colony formation, resulting in only small colonies ( Figure 6 ). These drugs were more effective on NUGC4 cells than on KATO III cells, consistent with previous observations that LY294002 restored NUGC4 cells to flat shapes, but showed little effect on KATOIII cells (Kobayashi et al., 2003) . These results suggest that the PI 3-kinase-MKK3/6-p38 MAP kinase pathway contributes to the malignant phenotype of signet-ring cell carcinomas.
Discussion
In this study, we demonstrated that activation of p38 MAP kinase caused rounding of well-differentiated adenocarcinoma cells similar to that induced by activation of PI 3-kinase, although vacuole formation or secretion of mucins was not observed. However, the inhibitor of p38 MAP kinase suppressed the capacity for anchorage-independent growth of signet-ring cell carcinoma cell lines in soft agar. Small GTPase Rac also induced a morphologic change similar to that induced by PI 3-kinase and p38 MAP kinase. In addition to this, we detected the active form of Rac, MKK3, and p38 MAP kinase in signet-ring carcinoma cell lines such as NUGC4 and KATOIII (Kobayashi et al., 1999) . These results suggest that the PI 3-kinase-Rac-MKK3/6-p38 MAP kinase signaling pathway plays an important role in the formation of signet-ring cell carcinomas. Rounding of the cells often implies abnormalities in the cytoskeleton and in cell adhesion. The present study provided evidence that the PI 3-kinase-Rac-MKK3/6-p38 MAP kinase signaling pathway modulates the process of this morphologic change. Cell-matrix and cellular interactions and integrity of cytoskeletal organization are essential for the establishment of epithelial shape and maintenance of the differentiated epithelial phenotype (Braga, 2000; Jamora and Fuchs, 2002) . Recently, it has been established that PI 3-kinase could Role of p38 MAP kinase in differentiation of carcinoma Q Xu et al be involved in regulating integrin-mediated adhesion and E-cadherin-mediated adherence junctions (Yamada and Geiger, 1997; Sander et al., 1998) . Moreover, the role of PI 3-kinase in the formation of specific actin structures, membrane ruffling, and subsequent stress fibers in cells induced by several growth factors, presumably by regulation of the small GTP-binding proteins Rho and Rac, has also been established . However, in our preliminary study, disappearance of paxillin from focal adhesion or E-cadheren from adheren junctions was not observed in BD110-expressing HCC2998 cells (data not shown), suggesting that rounding of the cells by BD110 expression might be mediated by cytoskeleton rearrangement rather than by loss of cell adhesion or adheren junctions. In addition to cytoskeletal rearrangements, Rac is implicated in activation of p38 MAP kinase (Coso et al., 1995) . The p38 MAP kinase pathway has been shown to modulate cytoskeletal organization and cell survival in a variety of cell types through the activation of MAP kinase-activated protein kinase-2 and -3 (MAPKAPK-2 and -3) and consequent phosphorylation of the small heat shock protein HSP27. HSP27 functions as a phosphorylation-regulated actincapping protein. Phosphorylation of HSP27 causes release of free actin filament barbed ends, which allows actin polymerization to promote filament reorganization and stabilization (Landry and Huot, 1995; Guay et al., 1997) . Although subtle, we observed the rounding of HCC2998 cells after expression of dominant-active HSP27 (Xu, unpublished result). Besides its effect on the actin cytoskeleton, p38 MAP kinase has also been reported to modulate the organization of microtubules (vom Dahl et al., 2001) . For example, stathmin, which is known as a microtubule destabilizer protein, has been suggested to be a substrate for p38 MAP kinase (Gavet et al., 1998; Parker et al., 1998; Cassimeris, 2002) . Indeed, our preliminary results suggest that introduction of an active type of stathmin in HCC2998 cells also affects the cell shape. Thus, it is possible that p38 MAP kinase can regulate the cell shape by regulating the organization of both actin and microtubules.
MUC1 is a transmembrane type of mucin that is often overexpressed by carcinomas, which has been suggested to play a role in promoting tumor malignancy (Hilkens et al., 1995; Gimmi et al., 1996) . In a previous paper, we showed that secretion of MUC1 is indeed enhanced in signet-ring cell carcinoma cells in an ErbB3-PI 3-kinase-dependent manner (Kobayashi et al., 2003) . The present study suggests that the expression of MUC1 is independent of the p38 MAP kinase cascade. Therefore, it is likely that there are at least two pathways activated by ErbB3 in signet-ring cell carcinomas, one is p38 MAP kinase-dependent, and the other is p38 MAP kinaseindependent.
Since SB203580 inhibits soft agar colony formation of signet-ring cell lines, it is likely that the p38 MAP kinase-dependent pathway is more important for the malignant phenotype than is the independent one. We searched for the binding proteins for PI 3-kinase in signet-ring cell carcinomas and found that Gab1 binds to PI 3-kinase in these cells. Gab1 has been shown to be involved in carcinogenesis (Laffargue et al., 1999; Kameda et al., 2001) . It is therefore interesting to speculate that Gab1 mediates signaling of the secretion pathway in these cells. Further studies on this are under way.
Materials and methods
Cell lines
The signet-ring cell carcinoma lines KATOIII, NUGC-4, HCC2998/BD110, and MKN45-1/BD110 were cultured in RPMI1640 medium supplemented with 10% FBS (Akiyama et al., 1988; Yamamoto et al., 1990; Kobayashi et al., 1999) . HCC2998/BD110 and MKN45-1/BD110 carry the BD110 Role of p38 MAP kinase in differentiation of carcinoma Q Xu et al gene, which is inducible by the Cre-LoxP system (Kanegae et al., 1995) .
Plasmids and transfection
BD110 contains the binding site for p110 in p85 at the aminoterminal end of p110, as well as the myc-tag (Kita et al., 1998; Kobayashi et al., 1999) . Expression vectors for HA-tagged wildtype p38 MAP kinase (pcDL-SRaHA1 wildtype p38) and a constitutively active form of MKK6 (pcDNA3.1( þ ) MKK6DA) were generous gifts from Dr E Nishida (Moriguchi et al., 1996) . Expression vectors for constitutively active Rac (pEF Bos HA Rac1 DA) and dominant-negative Rac (pEF Bos HA Rac1 DN) were kind gifts from Dr K Kaibuchi (Kuroda et al., 1996) . Transfection of HCC2998/BD110 and MKN45-1/BD110 was done by the calcium phosphate coprecipitation method coupled with glycerol shock treatment (Fronsdal et al., 2000) . Briefly, 20 h after seeding into 3.5 cm dishes, HCC2998/BD110 cells were incubated with calcium phosphate coprecipitates containing 2 mg of plasmid DNA and 2.5 mg of carrier DNA (salmon sperm) for 4 h. The cells were then treated with 20% glycerol for 3 min and further incubated in fresh medium. SB203580 (Calbiochem) was added to the medium after glycerol shock at a final concentration of 10 mm. The transfected cells were identified by green fluorescent protein (GFP). pEGFP-C1 was used as an expression vector for GFP (CLONTECH Laboratories, Palo Alto, CA, USA).
Generation of the cell line bearing the MKK6DA gene cDNA of MKK6DA was subcloned into pCALNLw to yield pCALNLw-MKK6DA (Kanegae et al., 1995) . The resulting plasmid was introduced into HCC2998 cells by electroporation. The neomycin-resistant colonies were selected, and the expression of the MKK6DA protein was examined after infection with AxCANCre (Cre), an adenovirus coding for Cre recombinase. Five colonies capable of expressing the MKK6DA protein were obtained and designated as HCC2998/MKK6DA. AxCANLacZ (LacZ) is an adenovirus coding for the LacZ gene instead of the Cre gene (Kanegae et al., 1995) .
Antibodies, immunoprecipitation, and Western blotting
Anti-phospho-p38 MAP kinase (Thr180/Tyr182) antibody and anti-Phospho-MKK3/6 (Ser189/207) antibody were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). Anti-p38 MAP kinase antibody (N-20) anti-MKK3 (I-20) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-HA monoclonal antibody (12CA5) was produced by hybridoma 12CA5 (ATCC1013365). Anti-human MUC1 antibody, clone DF3, was purchased from DakoCytomation (Glostrup, Denmark). Fluorophore-labeled goat anti-mouse IgG (H þ L), Alexa Fluor 488, was purchased from Molecular Probes (Eugene, OR, USA). For immunoprecipitation, HCC2998/ BD110 cells transfected with various expression vectors were lysed in NP40 buffer (20 mm Tris-HCl, pH 7.5, 150 mm NaCl, 5 mm EDTA, and 1% NP40). After centrifugation at 15 000 g for 5 min, the supernatants were used as cell lysates. The HAtagged proteins were precipitated with protein A Sepharose beads (Pharmacia, Peapack, NJ, USA) coupled with 12C5 in NP40 buffer. The beads were washed twice with NP40 buffer. For Western blotting, the blocking reaction was done with 5% nonfat dry milk or 1% bovine serum albumin in Trisbuffered saline with 0.1% Tween 20 (TBS-T). The blots were then treated with the primary antibodies in TBS-T containing 5% nonfat dry milk for 1 h. After washing three times with TBS-T, the membranes were incubated with peroxidaseconjugated secondary antibodies. After washing with TBS-T, the proteins were detected by ECL.
In vitro kinase assay HA-p38 MAP kinase was immunoprecipitated with 12CA5 from HCC2998 cells transfected with appropriate expression vectors together with pcDL-SRaHA1 wild-type p38. After washing three times with NP40 buffer and once with a kinase buffer (20 mm Tris-Cl, pH 7.5, 100 mm ATP 10 mm MgCl 2 ), protein kinase activity in the immunoprecipitates was analysed in 20 ml of the kinase buffer containing 15-50 kBq [g- 32 P]ATP and 1 mg GST-ATF2, which was purified from a cell lysate from E. coli harboring an expression vector for GEST-ATF2 Figure 6 Effect of SB203580 or LY294002 on anchorage-independent growth of signet-ring cell carcinoma lines. In all, 50 000 NUGC4 or KATOIII cells were cultured in soft agar for 6, 10, or 14 days in the absence or presence of LY294002 (20 mm) or SB203580 (1.0 or 3.0 mm) (a gift from Dr R Fukunaga in Osaka University). After incubation at 301C for 30 min, the reaction was stopped and 32 P incorporation into GST-ATF2 was measured by SDS electrophoresis followed by quantification with an imaging analyzer (Fujix BAS3000).
Immunocytochemistry
The cells were fixed with 10% formaldehyde at room temperature for 10 min, washed three times, and incubated with anti-MUC1 antibody, clone DF3 (Kufe et al., 1984) for 2 h. After washing three times, they were incubated with the secondary antibody (Alexa Fluor 488) for 1 h and observed under a fluorescence microscope.
Soft-agar colony-formation assay KATOIII and NUGC-4 (50 000 cells) were suspended in 1 ml of DMEM containing 10% FBS, 0.4% low-melting-temperature agarose (FMC BioProducts, Rockland, ME, USA) and drugs. The cell suspension was laid on top of 1 ml of DEME containing 0.8% agarose and the drugs in 35 cm tissue culture dishes, and incubated in a CO 2 incubator for 2 weeks to form colonies (Desprez et al., 1998) . After 1 week, 1 ml of DMEM containing 10% FBS, 0.4% low-melting-temperature agarose and the drugs was overlaid.
